These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 33084451)
21. Effect of Fatigue on Health-Related Quality of Life and Work Productivity in Psoriatic Arthritis: Findings From a Real-World Survey. Gossec L; Walsh JA; Michaud K; Holdsworth E; Peterson S; Meakin S; Yang F; Booth N; Chakravarty SD; Piercy J; Dennis N; Ogdie A J Rheumatol; 2022 Nov; 49(11):1221-1228. PubMed ID: 35840154 [TBL] [Abstract][Full Text] [Related]
22. Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis. Salvarani C; Girolomoni G; Di Lernia V; Gisondi P; Tripepi G; Egan CG; Marchesoni A; Semin Arthritis Rheum; 2016 Dec; 46(3):305-311. PubMed ID: 27470190 [TBL] [Abstract][Full Text] [Related]
23. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required? Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235 [TBL] [Abstract][Full Text] [Related]
24. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP). Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221 [TBL] [Abstract][Full Text] [Related]
26. Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). Kavanaugh A; Mease P J Rheumatol Suppl; 2012 Jul; 89():90-3. PubMed ID: 22751603 [TBL] [Abstract][Full Text] [Related]
27. Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis. Kenar G; Yarkan H; Zengin B; Can G; Birlik M; Önen F Rheumatol Int; 2018 Nov; 38(11):2069-2076. PubMed ID: 30194455 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of psoriatic arthritis in a large cohort of Brazilian patients with psoriasis. Ranza R; Carneiro S; Qureshi AA; Martins G; Rodrigues JJ; Romiti R; Barros TB; Carneiro J; Sampaio AL; Grynszpan R; Markus J; Pinto RM; Goldenstein-Schainberg C J Rheumatol; 2015 May; 42(5):829-34. PubMed ID: 25729032 [TBL] [Abstract][Full Text] [Related]
29. Determinants of radiographic progression in early psoriatic arthritis: insights from a real-world cohort. Koc GH; Kok MR; do Rosario Y; Luime JJ; Tchetverikov I; Kasiem FR; Korswagen LA; Bijsterbosch J; Goekoop-Ruiterman YPM; van Oosterhout M; Baudoin P; Kok P; Dolhain RJEM; Vis M RMD Open; 2024 May; 10(2):. PubMed ID: 38796181 [TBL] [Abstract][Full Text] [Related]
30. Impact of Enthesitis on Psoriatic Arthritis Patient-Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey. Orbai AM; Birt JA; Holdsworth EA; Booth N; Malatestinic WN; Sprabery AT; Reginato AM Rheumatol Ther; 2020 Dec; 7(4):937-948. PubMed ID: 33052584 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial. Walsh JA; Gottlieb AB; Hoepken B; Nurminen T; Mease PJ Clin Rheumatol; 2018 Dec; 37(12):3285-3296. PubMed ID: 30191421 [TBL] [Abstract][Full Text] [Related]
32. Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA. Richette P; Vis M; Ohrndorf S; Tillett W; Ramírez J; Neuhold M; van Speybroeck M; Theander E; Noel W; Zimmermann M; Shawi M; Kollmeier A; Zabotti A RMD Open; 2023 Mar; 9(1):. PubMed ID: 37001920 [TBL] [Abstract][Full Text] [Related]
33. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852 [TBL] [Abstract][Full Text] [Related]
34. Serum interleukin-23 levels: relation to depression, anxiety, and disease activity in psoriatic arthritis patients. Tabra SA; Abd Elghany SE; Amer RA; Fouda MH; Abu-Zaid MH Clin Rheumatol; 2022 Nov; 41(11):3391-3399. PubMed ID: 35861930 [TBL] [Abstract][Full Text] [Related]
35. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI). Mease PJ Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772 [No Abstract] [Full Text] [Related]
36. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population. Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701 [TBL] [Abstract][Full Text] [Related]
37. Sleep quality in patients with psoriatic arthritis. Gezer O; Batmaz İ; Sariyildiz MA; Sula B; Ucmak D; Bozkurt M; Nas K Int J Rheum Dis; 2017 Sep; 20(9):1212-1218. PubMed ID: 25363664 [TBL] [Abstract][Full Text] [Related]
38. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial. Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650 [TBL] [Abstract][Full Text] [Related]
39. Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool. López Estebaránz JL; Zarco-Montejo P; Samaniego ML; García-Calvo C; Eur J Dermatol; 2015; 25(1):57-63. PubMed ID: 25333645 [TBL] [Abstract][Full Text] [Related]